Status:
UNKNOWN
The Efficacy of Lower Dose Zolpidem for Achieving Satisfactory Sleep in Women With Disordered Sleep
Lead Sponsor:
Rhode Island Hospital
Collaborating Sponsors:
Vitae Industries, Inc
Conditions:
Sleep Disorder
Eligibility:
FEMALE
18-65 years
Brief Summary
Sleep difficulties are very common in adults in the U.S. today. Zolpidem (Ambien) is often prescribed as a first line agent to treat sleep difficulties in patients presenting with sleep related compla...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- biologically female
- age 18-65
- English speaking
- difficulty sleeping
- Exclusion Critieria:
- diagnosed significant cardiac, pulmonary, neuromuscular, hepatic, renal or major psychiatric disease (as ascertained by the study physicians)
- diagnosed sleep pathology such as sleep apnea or prior work-up for sleep pathology
- recent (two weeks prior) treatment of any kind for sleep disorder including herbal or over the counter treatments, psychiatric medications including anxiolytics except for SSRI's.
- pregnant or trying to become pregnant
Exclusion
Key Trial Info
Start Date :
January 31 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03786120
Start Date
January 31 2019
End Date
December 31 2019
Last Update
April 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
rhode island Hospital
Sacramento, California, United States, 95819